In Veritas Recruits Additional Science Resources

Market Wire, July, 2006

IVMD Inc, a novel medical device company (OTCBB: IVME), today announced that John Gilmour has joined the team in the Inverness Laboratories.

John, who has a degree in Immunology and an MBA, is an experienced Senior Manager and Scientist with over 20 years multifaceted experience in the biotech industry. He has a proven track record in product development, forging links with academic researchers and securing funds for commercialisation ventures. He has also applied excellent scientific, general managerial and project management skills to deliver real product.

John worked previously for Axis Shield and Stirling Diagnostics, and brings a wealth of experience in creating immunoassay tests and platforms. This will add to IVMD's patented technologies and create additional opportunities.

John said, "IVMD's products cover an exciting part of the marketplace. With the business fully focussed on the next generation of Immunoassay products, my knowledge will allow the business to accelerate the route to market. I am delighted to be able to join IVMD and apply my skills to help the business grow."

Graham Cooper, President and CEO, said, "John brings a number of strengths to help develop the next suite of products in our portfolio. This move is directly in line with our strategy of providing more focus on development and freeing up other resources to deliver commercialisation opportunities."

About IVMD, Inc.

IVMD uses its proven, patented core technology to design, develop and test medical devices for near patient testing and monitoring.

Our products serve large global markets in the monitoring of chronic conditions affecting large numbers of the population. Two applications form the focus of current development work. The first is a device for measuring the coagulation of blood in patients with cardiovascular disorders which is in the last stages of clinical trials. The second a device that predicts the onset of human labour up to several weeks before birth.

Our scientists are currently working on several exciting minimally and non invasive additional products based on novel, highly sensitive immunoassays. From across all sectors of industry, our development team use our technology to create rapid prototype and product development, in partnership with major marketing and distribution partners.

IVMD actively seeks bespoke product development, manufacturing, marketing and distribution agreements.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In particular, when used in the preceding discussion, the words "believe," "expects," "projects," "forecasts," "intends," "will," "anticipated," "could," or "may," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the act and are subject to the safe harbor created by the act. Except for historical information, all of the statements, expectations and assumptions contained in the foregoing are forward-looking statements that involve a number of risks and uncertainties.

Contact: IVMD (UK) Ltd. press@ivmd.com